Forbes.com: Virpax (NASDAQ: VRPX): A Promising Stock In A Sickly Biotech Market Jan 14, 2024 Forbes.com: Virpax (NASDAQ: VRPX): A Promising Stock In A Sickly Biotech Market admin2024-01-24T15:10:26-05:00January 14th, 2024|Media|